🔎 Trials Near Me

Home › Myasthenia Gravis › Pennsylvania

Pag-aaral pangklinika para sa Myasthenia Gravis sa Pennsylvania

6 pag-aaral para sa Myasthenia Gravis ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

  • The Childrens Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 2
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06987539

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

  • Penn State Milton S Hershey Medical Ctr, Hershey
  • Childrens Hospital Of Philadelphia, Philadelphia
Nagre-recruitPhase 2/3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT05265273

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Thomas Jefferson University Hospital, Philadelphia
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06193889

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Temple University Hospital, Philadelphia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT04202341

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

  • Thomas Jefferson University, Philadelphia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 11, 2025 · NCT05564936

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.